[Importance of appropriate carbapenem use to reduce carbapenem--resistant Pseudomonas aeruginosa].
Furukawa
Keiichi
K
Division of Infectious Diseases, Department of Medicine, St. Luke' s International Hospital.
D015780:Carbapenems / Q000008:administration & dosage* / Q000494:pharmacology; D017714:Community-Acquired Infections / Q000188:drug therapy / Q000517:prevention & control; D003428:Cross Infection / Q000188:drug therapy / Q000382:microbiology; D024901:Drug Resistance, Multiple, Bacterial; D004363:Drug Utilization; D006801:Humans; D007564:Japan; D018410:Pneumonia, Bacterial / Q000188:drug therapy / Q000517:prevention & control; D011552:Pseudomonas Infections / Q000188:drug therapy* / Q000382:microbiology; D011550:Pseudomonas aeruginosa / Q000187:drug effects / Q000302:isolation & purification; D012307:Risk Factors
D015780:Carbapenems